Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat

Journal of Neural Transmission

Volumn 106, Issue 7-8, 1999, Pages 593-606

  Speiser, Z ^a   Mayk, A ^b   Eliash, S ^a   Cohen, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

Focal ischemia; MAO inhibition; Neuroprotection; Rasagiline; Stroke

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DIZOCILPINE; MONOAMINE OXIDASE B INHIBITOR; RASAGILINE; SELEGILINE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG RESPONSE; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TIME;

ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; DRUG EVALUATION, PRECLINICAL; INDANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 0032807402     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050182     Document Type: Article

References (32)

1. Ansari KS, Yu PH, Krock TPA, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(-)deprenyl: stereoselectivity and independence from monoamine oxidase inhibition. J Neurosci 13: 4042-4053
2. Biagini G, Frasoldati A, Fuxe K, Agnati LF (1994) The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes. Neurochem Int 25: 17-22
3. Buys YM, Trope GE, Tatton WG (1995) (-)Deprenyl increases the survival of rat retinal ganglion cells after optic nerve growth. Curr Eye Res 14: 119-126
4. Carrillo MC, Kanai S, Sato Y, Ivy GO (1992) Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats. Biochem Pharmacol 44: 859-861
5. Carrillo MC, Kitani K, Kanai S, Sato Y, Ivy GO (1992) The ability of (-)deprenyl to increase Superoxide dismutase activities in the rat is tissue and brain region selective. Life Sc 50: 1985-1992
6. Cechetto DF, Wilson JX, Smith KE, Wolski D, Silver MD, Hachisnki VC (1989) Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat. Brain Res 502: 296-305
7. Finberg JPM, Lamensdorf I, Commissiong JW, Youdim MBH (1996) Pharmacology and neuroprotective properties of rasagiline. J Neural Transm [Suppl] 48: 95-101
8. Finberg JPM, Takeshima T, Johnston JM, Commissiong JW (1998) Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. Neuro Report 9: 703-707
9. Garcia JH, Wagner S, Liu K-F, Hu X-J (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26: 627-635
10. Ishitani R, Tanak M, Sunaga K, Katsube N, Chuang DM (1998) Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53: 701-707
11. Knollema S, Aukema W, Horn H, Korf J, Ter-Horst GJ (1995) L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke 26: 1883-1887
12. Kolb B, Sutherland RJ, Whishaw IQ (1983) A comparison of the frontal and parietal association cortex to spatial localizations in the rat. Behav Neurosci 97: 13-27
13. Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Muller D, van Oostrum J, Waldmeier P, Furst O (1998) Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptolic compounds CGP3466 and (R)-deprenyl. J Biol Chem 273: 5821-5828
14. Menzies SA, Hoff JT, Betz AL (1992) Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31: 100-106
15. Muller T, Kuhn W, Kruger R, Przuntek H (1998) Selegiline as immunostimulant-a novel mechanism of action? J Neural Transm [Suppl] 52: 321-328
16. Mytilineou C, Radcliffe P, Kokotos Leonardi E, Werner P, Olanow CW (1997) L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro. J Neurochem 68: 33-39
17. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988) The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 124: 543-551
18. Sauer D, Allegrini PR, Cosenti A, Pataki A, Amacker H, Fagg GE (1993) Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of local cerebral ischemia: an in vivo magnetic resonance imaging study. J Cereb Blood Flow Metab 13: 595-602
19. Scremin OU, Scremin AME (1986) Physostigmine induced reversal of ischemia following acute middle cerebral artery occlusion in the rat. Stroke 17: 1004-1009
20. Semkova I, Wolz P, Schilling M, Krieglstein J (1996) Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol 315: 19-30
21. Seniuk NA, Henderson JT, Tatton WG, Roder JC (1994) Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R(-)deprenyl. J Neurosci Res 37: 278-286
22. Simonson SG, Zhang J, Canad AT, Su YF, Benveniste H, Piantadosi CA (1993) Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain. J Cereb Blood Flow Metab 13: 125-134
23. Speiser Z, Katzir O, Rehavi M, Zabarski T, Cohen S (1998) Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the posnatal anoxia rat. Pharmacol Biochem Behav 60: 1-7
24. Speiser Z, Levy R, Cohen S (1998) Effects of propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. J Neural Transm [Suppl] 52: 287-300
25. Sweeny MI, Yager JY, Walz W, Juurlink BH (1995) Cellular mechanisms involved in brain ischemia. Can J Physiol Pharmacol 73: 1525-1535
26. Tamura A, Graham DI, McCullough J, Teasdale GH (1981) Focal cerebral ischemia in the rat. 1. Description of technique and early neuropathological consequences following MCA occlusion. J Cereb Blood Flow Metab 1: 53-60
27. Tatton WG, Chalmers Redman RM, Ju WY, Wadia J, Tatton NA (1997) Apotosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm [Suppl] 49: 245-268
28. Teasdale G, Tyson G, Tamura A, Graham DI, McCullough J (1983) Focal cerebral ischaemia in the rat: neuropathology, local cerebral blood flow and cerebrovascular permeability. In: Stephanovitch C (ed) Stroke: animal models. Pergamon Press, New York, pp 63-97
29. Wahl F, Allix M (1992) Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 23: 267-272
30. Yamamoto M, Tamura A, Kirino T, Shimitzu M, Sano K (1988) Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res 452: 323-328
31. Yamori Y, Horie R, Handa H, Sato M, Fukase M (1976) Pathogenic similarity of strokes in stroke prone spontaneously hypertensive rats and humans. Stroke 7: 46-53
32. Young W, DeCres-cito V, Flamm ES, Hadani M, Rappaport H, Cornu P (1986) Tissue Na, K and Ca change in regional cerebral ischemia: their measurement and interpretation. Central Nervous System Trauma 3: 215-234